Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using (18)F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST

OBJECTIVE: In malignant melanoma patients treated with immune checkpoint inhibitor (ICI) therapy, three different FDG-PET criteria, European Organization for Research and Treatment of Cancer (EORTC), PET Response Criteria in Solid Tumors (PERCIST), immunotherapy-modified PERCIST (imPERCIST), were co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitajima, Kazuhiro, Watabe, Tadashi, Nakajo, Masatoyo, Ishibashi, Mana, Daisaki, Hiromitsu, Soeda, Fumihiko, Tanemura, Atsushi, Kanekura, Takuro, Yamazaki, Naoya, Ito, Kimiteru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732811/
https://www.ncbi.nlm.nih.gov/pubmed/34287739
http://dx.doi.org/10.1007/s11604-021-01174-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732811/
https://www.ncbi.nlm.nih.gov/pubmed/34287739
http://dx.doi.org/10.1007/s11604-021-01174-w

Ejemplares similares